ANTI-CD6 ANTIBODY COMPOSITIONS AND METHODS FOR TREATING AND REDUCING NEGATIVE EFFECTS OF A CORONAVIRUS INCLUDING COVID-19

The present invention provides the use of anti-CD6 antibodies that specifically bind to domain 1 of CD6 for treating effects of a coronavirus or bacterial agent and particularly COVID-19 and variants thereof. The anti-CD6 antibodies of the present invention exhibit therapeutic activity by reducing t...

Full description

Saved in:
Bibliographic Details
Main Authors CROMBET RAMOS, Tania, RAMOS SUZARTE, Mayra, MAZUMDAR SHAW, Kiran, NAIR, Pradip, LEÓN MONZÓN, Kalet, RAMAKRISHNAN, Melarkode Subbaraman, CASIMIRO, Jose Enrique Montero, BUGHANI, Usha, ATHALYE, Sandeep Nilkanth
Format Patent
LanguageEnglish
Published 25.09.2024
Online AccessGet full text

Cover

More Information
Summary:The present invention provides the use of anti-CD6 antibodies that specifically bind to domain 1 of CD6 for treating effects of a coronavirus or bacterial agent and particularly COVID-19 and variants thereof. The anti-CD6 antibodies of the present invention exhibit therapeutic activity by reducing the overactive immune response, such as the high expression levels of cytokines.
Bibliography:Application Number: ZA20220010032